Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127116371 | 12711637 | 1 | I | 20160817 | 20160902 | 20160902 | PER | US-BAYER-2016-162308 | BAYER | 56.00 | YR | A | M | Y | 86.17000 | KG | 20160902 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127116371 | 12711637 | 1 | PS | CLARITIN-D 12 HOUR | LORATADINEPSEUDOEPHEDRINE SULFATE | 1 | Oral | 1 DF, QD | CVM02A0 | 19670 | 1 | DF | PROLONGED-RELEASE TABLET | QD | |||||
| 127116371 | 12711637 | 2 | SS | CLARITIN | LORATADINE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 127116371 | 12711637 | 3 | C | MULTIVITAMIN | VITAMINS | 1 | UNK | 0 | |||||||||||
| 127116371 | 12711637 | 4 | C | SULFASALAZINE. | SULFASALAZINE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127116371 | 12711637 | 1 | Seasonal allergy |
| 127116371 | 12711637 | 2 | Seasonal allergy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127116371 | 12711637 | Poor quality sleep | |
| 127116371 | 12711637 | Product use issue | |
| 127116371 | 12711637 | Therapeutic response unexpected |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |